Cannabidiol formulation
AssigneeHealthy Roots Inc.
InventorElizabeth Merritt
Life of this patent
Estimating the term…
Abstract
Cannabidiol (CBD) formulation comprising a mixture of full spectrum cannabidiol oil (FSO) and cannabidiol isolate (CBD isolate) is disclosed. The formulation contains a total amount of CBD derived from a combination of an amount of CBD in the FSO and an amount of CBD from the CBD isolate. The formulation of FSO and CBD isolate in used for medicinal and health benefits in a wide range of products, such as tinctures, capsules, creams or lotions, bath salts or bombs, soaps, pet or animal tinctures, and pet or animal edible chews.
Claims20
A cannabidiol (CBD) formulation comprising full spectrum cannabidiol oil (FSO), and cannabidiol isolate (CBD isolate), wherein the FSO and CBD isolate contribute an amount of CBD to the formulation.
A cannabidiol (CBD) tincture comprising approximately 3% (wt.) CBD, full spectrum cannabidiol oil (FSO), and cannabidiol isolate (CBD isolate), wherein the formulation contains less than 0.3% (wt.) tetrahydrocannabinol (THC).
A method for production of a cannabidiol (CBD) formulation comprising:
- obtaining an amount of a full spectrum cannabidiol oil (FSO) containing CBD;
- obtaining an amount of a cannabidiol isolate (CBD isolate) containing CBD;
- determining by analytical testing the CBD content of the FSO;
- determining by analytical testing the CBD content of the CBD isolate;
- mixing the FSO and the CBD isolate to produce the formulation, wherein the formulation comprises an amount of CBD, wherein the ratio of FSO to CBD isolate ranges from 80% FSO and 20% CBD Isolate, to 55% FSO and 45% CBD isolate, and wherein the formulation contains less than 7% (wt.) tetrahydrocannabinol (THC).
Dependencies are inferred from the claim text.